Literature DB >> 19394375

Zinc-finger-based artificial transcription factors and their applications.

Takashi Sera1.   

Abstract

Artificial transcription factors (ATFs) are potentially a powerful molecular tool to modulate endogenous target gene expression in living cells and organisms. To date, many DNA-binding molecules have been developed as the DNA-binding domains for ATFs. Among them, ATFs comprising Cys(2)His(2)-type zinc-finger proteins (ZFPs) as the DNA-binding domain have been extensively explored. The zinc-finger-based ATFs specifically recognize targeting sites in chromosomes and effectively up- and downregulate expression of their target genes not only in vitro, but also in vivo. In this review, after briefly introducing Cys(2)His(2)-type ZFPs, I will review the studies of endogenous human gene regulation by zinc-finger-based ATFs and other applications as well.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394375     DOI: 10.1016/j.addr.2009.03.012

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  46 in total

1.  Functional rules for lac repressor-operator associations and implications for protein-DNA interactions.

Authors:  Leslie Milk; Robert Daber; Mitchell Lewis
Journal:  Protein Sci       Date:  2010-06       Impact factor: 6.725

Review 2.  Experimental strategies for studying transcription factor-DNA binding specificities.

Authors:  Marcel Geertz; Sebastian J Maerkl
Journal:  Brief Funct Genomics       Date:  2010-09-23       Impact factor: 4.241

Review 3.  The New State of the Art: Cas9 for Gene Activation and Repression.

Authors:  Marie F La Russa; Lei S Qi
Journal:  Mol Cell Biol       Date:  2015-09-14       Impact factor: 4.272

4.  Transcriptional refractoriness is dependent on core promoter architecture.

Authors:  François Cesbron; Michael Oehler; Nati Ha; Gencer Sancar; Michael Brunner
Journal:  Nat Commun       Date:  2015-04-08       Impact factor: 14.919

5.  Hypoxia-specific downregulation of endogenous human VEGF-A gene by hypoxia-driven expression of artificial transcription factor.

Authors:  Tomoaki Mori; Jun Sasaki; Yasuhiro Aoyama; Takashi Sera
Journal:  Mol Biotechnol       Date:  2010-10       Impact factor: 2.695

Review 6.  New approaches for modelling sporadic genetic disease in the mouse.

Authors:  Elizabeth M C Fisher; Eva Lana-Elola; Sheona D Watson; George Vassiliou; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2009 Sep-Oct       Impact factor: 5.758

7.  The prospects for designer single-stranded RNA-binding proteins.

Authors:  Joel P Mackay; Josep Font; David J Segal
Journal:  Nat Struct Mol Biol       Date:  2011-02-27       Impact factor: 15.369

8.  Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion.

Authors:  Monique G P van der Wijst; Christian Huisman; Archibold Mposhi; Gerard Roelfes; Marianne G Rots
Journal:  Mol Oncol       Date:  2015-03-19       Impact factor: 6.603

9.  Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm.

Authors:  Jacob S Appelbaum; Jonathan R LaRochelle; Betsy A Smith; Daniel M Balkin; Justin M Holub; Alanna Schepartz
Journal:  Chem Biol       Date:  2012-07-27

10.  Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors.

Authors:  Christian Huisman; G Bea A Wisman; Hinke G Kazemier; Marcel A T M van Vugt; Ate G J van der Zee; Ed Schuuring; Marianne G Rots
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.